The speaker's practice prioritizes rosuvastatin, atorvastatin, pravastatin, and lovastatin, often preferring branded versions due to potential differences in generic efficacy.

“in our practice we really only pick from four of them livolo crestor lipitor and prevastatin i mean most of these are generic now and if you listen to the podcast with catherine eben which i know you did we are actually still pushing for branded whenever we can get it and if we're not getting a branded version of those we cross check with who the generic supplier is and we've seen differences right we've seen that a two versions of rosuvastatin can produce different outcomes so our default position is that all generics are crap until proven otherwise and that's why we use a tightly controlled list of of meds”